Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients

Cancer Research

Volumn 56, Issue 18, 1996, Pages 4134-4136

  Taubert, Helge ^a   Meye, Axel ^a   Würl, Peter ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; SOFT TISSUE SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SARCOMA; SEQUENCE DELETION; SURVIVAL RATE;

EID: 0029810442     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Diccianni, M. B , Yu, J., Hsiao, M , Mukherjee, S., Shao, L-E , and Yu, A. L. Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood, 84, 3105-3112, 1994
2. Hamelin, R., Laurent-Puig, P , Olschwang, S , Jego, N., Asselain, B , Remvikos, Y , Girodet, J., Salmon, R. J., and Thomas, G. Association of p53 mutations with short survival in colorectal cancer. Gasteroenterology, 106, 42-48, 1994.
3. Goh, H. S., Yao, J., and Smith, D. R. p53 point mutation and survival in colorectal cancer patients. Cancer Res., 55: 5217-5221, 1995.
4. Hollstein, M., Sidransky, D , Vogelstein, B., and Harris, C. C p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
5. Hollstein, M , Shomer, B., Greenblatt, M , Soussi, T., Hovig, E., Montesano, R., and Harris, C. C. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation Nucleic Acids Res., 24: 141-146, 1996.
6. Hartmann, A , Blaszyk, H., McGovern, R. M., Schroeder, J. J., Cunningham, J., De Vries, E. M G , Kovach, J. S., and Sommer, S. S. p53 gene mutations inside and outside of exon 5-8: patterns differ in breast and other cancers Oncogene, 10: 681-688, 1995.
7. Greenblatt, M. S., Bennett, W. P , Hollstein, M., and Harris, C C. Mutations in the p53 tumor suppressor gene. clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
8. Bergh, J , Norberg, T., Sjögren, S., Lindgren, A , and Holmberg, L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat. Med , 1: 1029-1034, 1995.
9. Finlay, C. A., Hinds, P. W., and Levine, A. J The p53 proto-oncogene can act as a suppressor of transformation Cell, 57: 1083-1093, 1989.
10. Dittmer, D , Pati, S., Zambetti, G., Chu, S , Teresky, A. K., Moore, M., Finlay, C , and Levine, A J. Gain function mutations in p53. Nat Genet., 4: 42-46, 1993.
11. Wadayama, B., Toguchida, J., Yamaguchi, T., Sasaki, M. S., Kotoura, Y., and Yamamuro, T. P53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br. J. Cancer, 68. 1134-1139, 1993.
12. Cordon-Cardo, C., Latres, E , Drobnjak, M., Oliva, M R , Pollack, D., Woodruff, J. M., Marechal, V , Chen, J., Brennan, M. F , and Levine, A. J. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas Cancer Res., 54 794-799, 1994.
13. Taubert, H., Wurl, P., Meye, A , Berger, D., Thamm, B., Neumann, K., Hinze, R , Schmidt, H., and Rath, F-W. Molecular and immunohistochemical status in liposarcoma and malignant fibrous histiocytoma. Cancer (Phila), 76: 1187-1196, 1995.
14. Würl, P., Taubert, H , Bache, M., Kroll, J., Meye, A , Siermann, A., Holzhausen, H-J , Hinze, R., Schmidt, H., and Rath, F-W. Frequent occurrence of p53 mutations in rhabdo- and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors. Int. J. Cancer, 69 , 317-323, 1996.
15. Fong, Y., Coit, D. G., Woodruff, J. M , and Brennan, M. F. Lymph node metastasis from soft tissue sarcoma in adults, analysis of data from a prospective database of 17772 sarcoma patients. Ann. Surg., 217. 72-77, 1993.
16. Aas, T., Borresen, A-L., Geisler, S , Smith-Sorensen, B., Johnsen, H., Varhaug, J. E., Akslen, L A., and Lonning, P. E Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat. Med., 2: 811-814, 1996.